Bile Acids Activate YAP to Promote Liver Carcinogenesis

Slides:



Advertisements
Similar presentations
Hepatitis C and Alcohol Exacerbate Liver Injury by Suppression of FOXO3  Batbayar Tumurbaatar, Irina Tikhanovich, Zhuan Li, Jinyu Ren, Robert Ralston,
Advertisements

The BH3-Only Protein Bid Does Not Mediate Death-Receptor-Induced Liver Injury in Obstructive Cholestasis  Padmavathi devi Nalapareddy, Sven Schüngel,
Volume 4, Issue 12, Pages (December 2015)
Volume 22, Issue 6, Pages (December 2012)
Volume 16, Issue 3, Pages (July 2016)
Volume 123, Issue 5, Pages (November 2002)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 136, Issue 1, Pages e2 (January 2009)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 15, Issue 1, Pages (January 2012)
C-kit Inhibition by Imatinib Mesylate Attenuates Progenitor Cell Expansion and Inhibits Liver Tumor Formation in Mice  Belinda Knight, Janina E.E. Tirnitz–Parker,
Volume 143, Issue 6, Pages (December 2012)
Volume 91, Issue 3, Pages (March 2017)
Reginald Hill, Yurong Song, Robert D. Cardiff, Terry Van Dyke  Cell 
Volume 150, Issue 3, Pages (March 2016)
David A. Cano, Shigeki Sekine, Matthias Hebrok  Gastroenterology 
Volume 124, Issue 1, Pages (January 2003)
Volume 21, Issue 6, Pages (June 2012)
Volume 129, Issue 5, Pages (November 2005)
Volume 129, Issue 2, Pages (August 2005)
Volume 66, Issue 1, Pages (January 2017)
Volume 84, Issue 5, Pages (November 2013)
Volume 42, Issue 2, Pages (February 2005)
Volume 29, Issue 4, Pages (April 2016)
Growth Arrest Failure, G1 Restriction Point Override, and S Phase Death of Sensory Precursor Cells in the Absence of Neurotrophin-3  Wael M ElShamy, Lena.
Volume 69, Issue 2, Pages (August 2018)
Volume 24, Issue 6, Pages (August 2018)
Volume 8, Issue 4, Pages (August 2014)
Volume 119, Issue 6, Pages (December 2000)
Volume 115, Issue 5, Pages (November 1998)
Volume 127, Issue 6, Pages (December 2004)
Volume 13, Issue 8, Pages (November 2015)
Volume 143, Issue 1, Pages e7 (July 2012)
Volume 141, Issue 1, Pages e4 (July 2011)
Volume 18, Issue 13, Pages (March 2017)
Volume 19, Issue 5, Pages (May 2011)
Volume 18, Issue 9, Pages (September 2010)
Role of Connective Tissue Growth Factor in Oval Cell Response During Liver Regeneration After 2-AAF/PHx in Rats  Liya Pi, Seh-Hoon Oh, Thomas Shupe, Bryon.
Volume 15, Issue 3, Pages (September 2014)
Volume 22, Issue 6, Pages (December 2012)
Volume 135, Issue 2, Pages (August 2008)
Volume 138, Issue 7, Pages (June 2010)
Maria L. Golson, Kathleen M. Loomes, Rebecca Oakey, Klaus H. Kaestner 
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Volume 130, Issue 7, Pages (June 2006)
Volume 14, Issue 10, Pages (March 2016)
Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin 
Volume 16, Issue 1, Pages (July 2012)
Volume 132, Issue 4, Pages (April 2007)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 127, Issue 3, Pages (September 2004)
Volume 7, Issue 1, Pages (January 2008)
Volume 19, Issue 8, Pages (August 2011)
Volume 144, Issue 5, Pages e4 (May 2013)
Volume 15, Issue 3, Pages (April 2016)
Bile Acids Activate YAP to Promote Liver Carcinogenesis
Effectively regenerating livers transiently accumulate proliferative IGF2BP3-positive cells. Effectively regenerating livers transiently accumulate proliferative.
Volume 21, Issue 6, Pages (June 2012)
Volume 12, Issue 4, Pages (July 2015)
Volume 8, Issue 2, Pages (July 2014)
Volume 7, Issue 6, Pages (June 2008)
Teemu P. Miettinen, Mikael Björklund  Cell Reports 
Production of nerve growth factor by mouse hepatocellular carcinoma cells and expression of TrkA in tumor-associated arteries in mice  Kan Kishibe, Yoshihisa.
Volume 1, Issue 4, Pages (April 2000)
Volume 6, Issue 2, Pages (August 2004)
Volume 11, Issue 2, Pages (August 2018)
Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma  Myoung Sook Han, Tamera Barrett, Michael.
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 27, Issue 9, Pages (September 2019)
Volume 9, Issue 2, Pages (October 2014)
Presentation transcript:

Bile Acids Activate YAP to Promote Liver Carcinogenesis Sayeepriyadarshini Anakk, Manoj Bhosale, Valentina A. Schmidt, Randy L. Johnson, Milton J. Finegold, David D. Moore  Cell Reports  Volume 5, Issue 4, Pages 1060-1069 (November 2013) DOI: 10.1016/j.celrep.2013.10.030 Copyright © 2013 The Authors Terms and Conditions

Cell Reports 2013 5, 1060-1069DOI: (10.1016/j.celrep.2013.10.030) Copyright © 2013 The Authors Terms and Conditions

Figure 1 Fxr−/−Shp−/− Mice Develop Spontaneous Hepatocellular Carcinoma and Phenocopy Mst1−/−/Mst2−/− Mice (A) Gross liver examination shows the presence of multiple tumor nodes with 100% penetrance compared to tumor-free WT mice (n = 20). (B) Progressive tumor growth is evident from increasing liver to body weight ratio of DKO mice with age. (C–E) Hepatic oval cell marker, OC21D11 (red), shows increased staining in 8- to 10-week-old DKO (D) compared to WT (C) mice and its quantification is shown in (E). DAPI (blue) stains the nuclei (n = 4–6). (F–H) Hematoxylin and eosin (H&E) staining of a year-old normal liver WT (F) and a DKO liver (G and H). DKO mice develop adenomas, whose growth rate exceeds the adjacent host liver (G), and HCC, with marked nuclear atypia and mitotic activity (H); the inset shows cholangiofibrosis. Arrowheads show fat accumulation, arrows point to focal inflammation, and the dotted line demarcates the adenoma boundary from the injured liver tissue. Magnification is 120×, and insets are 250×. ∗p < 0.05, ∗∗p < 0.001 compared to WT. Cell Reports 2013 5, 1060-1069DOI: (10.1016/j.celrep.2013.10.030) Copyright © 2013 The Authors Terms and Conditions

Figure 2 BA Overload Is Sufficient to Induce YAP Activation (A) Gene expression analysis in DKO mice indicates induction of YAP targets. (B) Immunoblot confirms reduced levels of inactive phospho YAP and activation of its targets in 5- to 8-week-old DKO animals compared to WT. (C) WT primary hepatocytes upon treatment with DKO serum display YAP activation, which can be mimicked with the bile acid chenodeoxycholic acid (CDCA). (D) CDCA induces YAP target CTGF. (E and F) WT mice fed a 1% CA diet (E) or 0.1% DDC diet (F) for 2 weeks display YAP activation compared to chow-fed animals. Densitometry was performed on immunoblots for n = 3–5 animals per group, and fold differences in comparison to control WT are written in parentheses. Cell Reports 2013 5, 1060-1069DOI: (10.1016/j.celrep.2013.10.030) Copyright © 2013 The Authors Terms and Conditions

Figure 3 BA Overload Does Not Cause Overt Cell Death but Alters Canonical Hippo Signaling (A–D) Primary hepatocytes were cultured and treated with DMSO (A) and varying doses of CDCA (B–D) overnight. (E) Cells were fixed and TUNEL-positive green-stained nuclei (marked with white arrows) were counted in at least ten different fields for each of the treatment groups to quantify cell death. We performed this experiment in triplicate. ∗∗p < 0.001 when compared to WT, CDCA 75 μM; #p < 0.01 when compared to CDCA 150 μM. Magnification is 120×. (F–H) Immunoblots for hippo pathway kinases were performed in DKO (F) and WT animals treated with either 1% CA (G) or 0.1% DDC (H) for 2 weeks. Hippo kinases were altered only in DKO and in CA-fed mice with no changes in DDC-fed WT animals. However, YAP targets CTGF and Cyclin D1 were induced upon CA and DDC treatment, clearly indicating YAP activation in these cholestatic mouse models. Densitometry was performed on immunoblots for n = 3–4 animals per group. Fold differences in comparison to control WT are in parentheses. Cell Reports 2013 5, 1060-1069DOI: (10.1016/j.celrep.2013.10.030) Copyright © 2013 The Authors Terms and Conditions

Figure 4 Increased IQGAP1 Expression Correlates Strongly with YAP Activation (A–C) Iqgap1 is robustly induced in DKO (A), WT (B), and in Iqgap2−/− animals treated with a 1% CA diet (C) compared to their respective controls. (D–F) The 1% CA treatment leads to elevated liver enzymes in the serum of Iqgap2−/− mice. (G) Immunoblot shows YAP activation in naive Iqgap2−/− mice. (H) Immunohistochemistry reveals abundant YAP expression with increased nuclear YAP in Iqgap2−/− compared to WT mouse livers after 1%CA diet (insets). Magnification is 120×. ∗p < 0.05 compared to WT mice on normal chow. Cell Reports 2013 5, 1060-1069DOI: (10.1016/j.celrep.2013.10.030) Copyright © 2013 The Authors Terms and Conditions

Figure 5 Iqgap1 Is Crucial for BA-Mediated Hepatocyte Proliferation (A–F) WT (A and B), Iqgap1−/− (C and D), and Iqgap2−/− (E and F) mice were fed a 1% CA diet for 2 weeks. (G) Ki-67 staining was performed in these samples to assess cellular proliferation. n = 3–4 mice per group were stained with Ki-67, and the positively stained brown nuclei were quantified. ∗p < 0.001 compared to WT a and Iqgap2−/− b. Magnification used is 120×. Cell Reports 2013 5, 1060-1069DOI: (10.1016/j.celrep.2013.10.030) Copyright © 2013 The Authors Terms and Conditions

Figure 6 IQGAP1 overexpression Is Sufficient to Increase YAP Levels and to Increase Hepatocyte Proliferation (A) Hepatic Iqgap1 overexpression results in YAP activation. (B) This is quantitated using immunoblots. (C–G) Iqgap1 overexpression for a period of 2 weeks results in slightly elevated serum ALT, but not AST, levels (C and D) and increased liver size (E and F) with no change in serum bile acid concentration (G). Robust YAP expression is observed in all hepatocytes after Iqgap1 overexpression, which correlates well with the increased proliferation observed with Ki-67 staining (inset). Densitometry on immunoblots for n = 3–5 animals per group. Fold differences in comparison to control WT are in parentheses. Magnification is 120×, and insets are 250×. ∗p < 0.05 compared to WT. Cell Reports 2013 5, 1060-1069DOI: (10.1016/j.celrep.2013.10.030) Copyright © 2013 The Authors Terms and Conditions

Figure 7 Human Biliary Disorders Exhibit Strong YAP and IQGAP1 Expression (A) Normal liver: bile duct epithelium has uniform cytoplasmic expression of both YAP and IQGAP1 proteins. Arterial smooth muscle is also positive. IQGAP1 is also expressed in sinusoidal Kupffer cells. (B) A 2 year old with congenital hepatic fibrosis: all ducts express IQGAP1 and YAP in cytoplasm and YAP in some nuclei. (C) Extrahepatic biliary atresia in a 2 week old. In addition to ductular expression of both proteins in the cytoplasm, many ductal and ductular and some hepatocyte nuclei are positive for YAP. (D) PFIC3 (progressive familial intrahepatic cholestasis 3). The expression pattern is identical to that of extra hepatic biliary atresia. Original magnification is 120× with purple staining for YAP (top) and red staining for IQGAP1 (bottom). (E) Human adenoma and hepatocellular carcinoma samples stained with YAP and IQGAP1. (F) Model illustrating how elevated BAs cause YAP activation. Cell Reports 2013 5, 1060-1069DOI: (10.1016/j.celrep.2013.10.030) Copyright © 2013 The Authors Terms and Conditions